Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Delayed Data
As of Sep 22
 -2.33 / -1.34%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 250.00, with a high estimate of 405.00 and a low estimate of 134.00. The median estimate represents a +45.76% increase from the last price of 171.52.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.99%
Growthannually 34.66%


Growthquarterly 10.06%
Growthannually 34.02%
Key to the earnings and sales forecast charts.